ProMIS Neurosciences Announces Full Year 2023 Financial Results and Recent Highlights

Apr 01, 2024 21:00

Top-line data from first-in-human Phase 1a clinical trial of PMN310 as a treatment for Alzheimer’s disease on track for mid-2024 Read More

Ads Links by Easy Branches
Play online games for free at games.easybranches.com
Guest Post Services www.easybranches.com/contribute